Eric Coldwell
Stock Analyst at Robert W. Baird
(4.48)
# 1,088
Out of 4,399 analysts
778
Total ratings
56.9%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Maintained: Buy | $56 → $45 | $36.54 | +23.15% | 3 | Jun 2, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $119 → $168 | $144.59 | +16.19% | 69 | May 29, 2026 | |
| ACH Accendra Health | Maintained: Buy | $7 → $6 | $2.74 | +118.98% | 72 | May 12, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $193 → $213 | $186.29 | +14.34% | 70 | May 8, 2026 | |
| MCK McKesson | Maintained: Buy | $974 → $941 | $790.44 | +19.05% | 77 | May 8, 2026 | |
| COR Cencora | Maintained: Buy | $415 → $339 | $281.24 | +20.54% | 74 | May 7, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $16 → $18 | $9.93 | +81.27% | 40 | May 6, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | $16 → $20 | $16.34 | +22.40% | 14 | May 6, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $252 → $248 | $216.30 | +14.66% | 69 | May 1, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $326 → $334 | $268.63 | +24.33% | 73 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $564 → $477 | $465.73 | +2.42% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $229 | $203.78 | +12.38% | 59 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $224 → $258 | $182.17 | +41.63% | 66 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $98.02 | n/a | 28 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $5.10 | n/a | 6 | May 9, 2014 |
Medline
Jun 2, 2026
Maintained: Buy
Price Target: $56 → $45
Current: $36.54
Upside: +23.15%
ICON Public Limited Company
May 29, 2026
Maintained: Buy
Price Target: $119 → $168
Current: $144.59
Upside: +16.19%
Accendra Health
May 12, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $2.74
Upside: +118.98%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $193 → $213
Current: $186.29
Upside: +14.34%
McKesson
May 8, 2026
Maintained: Buy
Price Target: $974 → $941
Current: $790.44
Upside: +19.05%
Cencora
May 7, 2026
Maintained: Buy
Price Target: $415 → $339
Current: $281.24
Upside: +20.54%
AdaptHealth
May 6, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $9.93
Upside: +81.27%
Fortrea Holdings
May 6, 2026
Maintained: Buy
Price Target: $16 → $20
Current: $16.34
Upside: +22.40%
Cardinal Health
May 1, 2026
Maintained: Buy
Price Target: $252 → $248
Current: $216.30
Upside: +14.66%
Labcorp Holdings
May 1, 2026
Maintained: Buy
Price Target: $326 → $334
Current: $268.63
Upside: +24.33%
Apr 24, 2026
Maintained: Buy
Price Target: $564 → $477
Current: $465.73
Upside: +2.42%
Apr 22, 2026
Maintained: Hold
Price Target: $219 → $229
Current: $203.78
Upside: +12.38%
Oct 29, 2025
Upgraded: Buy
Price Target: $224 → $258
Current: $182.17
Upside: +41.63%
Apr 18, 2022
Maintained: Hold
Price Target: $110
Current: $98.02
Upside: n/a
May 9, 2014
Rated: Buy
Price Target: $23 → $22
Current: $5.10
Upside: n/a